Buy or sell Aptiv Solutions stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Aptiv Solutions Stock

Aptiv is a biopharmaceutical and medical device company that offers a variety of clinical trial services.

Founded

1983

Headquarters

Reston VA, US

Total Funding

$5.7M

About Aptiv Solutions Stock

Aptiv Solutions, Inc. operates as a clinical research organization that offers clinical trial services. The company also provides adaptive trial design, simulation, and execution; early phase development consulting; pre clinical development; and drug development services. The company also provides regulatory compliance consulting services, which include strategy development, agency advisory, legal representation, and submission management services. It also offers therapeutic services in the areas of oncology, cardiology, dermatology, respiratory, and orphan diseases. Further, the company develops AptivAdvantage, an integrated technology platform for the implementation and execution of adaptive clinical trials. Aptiv Solutions, Inc. was formerly known as Averion International Corp. and changed its name to Aptiv Solutions, Inc. in February 2011. The company was founded in 1983 and is based in Reston, Virginia with an office in Durham, North Carolina.

Funding History

April 2012$5.7M

Management

Executive VP & COO

Michael McKelvey

Chairman and CEO

Patrick K. Donnelly

Executive VP & CMO

Gene Resnick

CFO

Matthew Bond

Executive VP and Chief Commercial Officer

Luis T. Gutierrez

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Aptiv Solutions or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo